Denicar Lina Nascimento Fabris Maeda

Denicar Lina Nascimento Fabris Maeda

Auto-generated profile, based on publicly available information

Denicar Lina Nascimento Fabris Maeda

Department of Pediatrics, University of Virginia, Charlottesville, VA 22908-0386

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DMDenicar Lina Nascimento Fabris Maeda
Denicar Lina Nascimento Fabris Maeda
DTDebin Tian
Debin Tian
HYHanna Yu
Hanna Yu
NDNakul Dar
Nakul Dar
VRVignesh Rajasekaran
Vignesh Rajasekaran
Steven ZeichnerSteven Zeichner
Steven Zeichner
Significance: We report a vaccine platform to express vaccine antigens on the surface of genome-reduced bacteria to enhance vaccine immunogenicity. We demonstrate the utility of this vaccine platform by expressing the highly conserved fusion peptide (FP) of SARS-CoV-2 and porcine epidemic diarrhea virus on the surface of Escherichia coli to produce killed whole-cell bacterial vaccines. The vaccine primes a potent anamnestic response, potentiates interferon-γ responses, and provides significant protection in pigs against disease following virus challenge. The FP could be a target for a broadly protective coronavirus vaccine since a betacoronavirus SARS-CoV-2 FP vaccine provided cross-protection against alphacoronavirus porcine epidemic diarrhea virus. When using a vaccine-appropriate bacteria vector, this inexpensive vaccine platform offers the potential for use in developing countries.